LEUKEMIA

Publications

  1. 2015
  2. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

    Mai, E. K., Bertsch, U., Dürig, J., Kunz, C., Haenel, M., Blau, I. W., Munder, M., Jauch, A., Schurich, B., Hielscher, T., Merz, M., Huegle-Doerr, B., Seckinger, A., Hose, D., Hillengass, J., Raab, M. S., Neben, K., Lindemann, H-W., Zeis, M., Gerecke, C., Schmidt-Wolf, I. G. H., Weisel, K., Scheid, C., Salwender, H. & Goldschmidt, H., 08.2015, In: LEUKEMIA. 29, 8, p. 1721-9 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

    Malinowska-Ozdowy, K., Frech, C., Schönegger, A., Eckert, C., Cazzaniga, G., Stanulla, M., Zur Stadt, U., Mecklenbräuker, A., Schuster, M., Kneidinger, D., von Stackelberg, A., Locatelli, F., Schrappe, M., Horstmann, M. A., Attarbaschi, A., Bock, C., Mann, G., Haas, O. A. & Panzer-Grümayer, R., 28.04.2015, In: LEUKEMIA. 29, 8, p. 1656-1667

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Grb10 is involved in BCR-ABL-positive leukemia in mice

    Illert, A. L., Albers, C., Kreutmair, S., Leischner, H., Peschel, C., Miething, C. & Duyster, J., 04.2015, In: LEUKEMIA. 29, 4, p. 858-68 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

    Waizenegger, J. S., Ben-Batalla, I., Weinhold, N., Meissner, T., Wroblewski, M., Janning, M., Riecken, K., Binder, M., Atanackovic, D., Taipaleenmaeki, H., Schewe, D., Sawall, S., Gensch, V., Cubas-Cordova, M., Seckinger, A., Fiedler, W., Hesse, E., Kröger, N., Fehse, B., Hose, D., Klein, B., Raab, M. S., Pantel, K., Bokemeyer, C. & Loges, S., 01.03.2015, In: LEUKEMIA. 29, 3, p. 696-704 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

    Heuser, M., Meggendorfer, M., Cruz, M. M. A., Fabisch, J., Klesse, S., Köhler, L., Göhring, G., Ganster, C., Shirneshan, K., Gutermuth, A., Cerny-Reiterer, S., Krönke, J., Panagiota, V., Haferlach, C., Koenecke, C., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Ehrlich, S., Stamer, K., Döhner, K., Valent, P., Schlegelberger, B., Kroeger, N., Ganser, A., Haase, D., Haferlach, T. & Thol, F., 24.02.2015, In: LEUKEMIA. 29, 9, p. 1942-45

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  7. SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

    Bartels, S., Lehmann, U., Büsche, G., Schlue, J., Mozer, M., Stadler, J., Triviai, I., Alchalby, H., Kröger, N-M. & Kreipe, H., 01.2015, In: LEUKEMIA. 29, 1, p. 253-5 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  8. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: Prognostic relevance of early and late assessment

    Eckert, C., Hagedorn, N., Sramkova, L., Mann, G., Panzer-Grümayer, R., Peters, C., Bourquin, J-P., Klingebiel, T., Borkhardt, A., Cario, G., Alten, J., Escherich, G., Astrahantseff, K., Seeger, K., Henze, G. & von Stackelberg, A., 2015, In: LEUKEMIA. 29, 8, p. 1648-1655

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2014
  10. Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

    Stern, M., de Wreede, L. C., Brand, R., van Biezen, A., Dreger, P., Mohty, M., de Witte, T. M., Kröger, N. & Ruutu, T., 01.11.2014, In: LEUKEMIA. 28, 11, p. 2235-40 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells

    Braig, M., Pällmann, N., Preukschas, M., Steinemann, D., Hofmann, W., Gompf, A., Streichert, T., Braunschweig, T., Copland, M., Rudolph, K. L., Bokemeyer, C., Koschmieder, S., Schuppert, A., Balabanov, S. & Brümmendorf, T. H., 01.10.2014, In: LEUKEMIA. 28, 10, p. 2028-39 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

    Barosi, G., Tefferi, A., Besses, C., Birgegard, G., Cervantes, F., Finazzi, G., Gisslinger, H., Griesshammer, M., Harrison, C., Hehlmann, R., Hermouet, S., Kiladjian, J-J., Kröger, N., Mesa, R., Mc Mullin, M. F., Pardanani, A., Passamonti, F., Samuelsson, J., Vannucchi, A. M., Reiter, A., Silver, R. T., Verstovsek, S., Tognoni, G. & Barbui, T., 25.08.2014, In: LEUKEMIA.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.08.2014, In: LEUKEMIA. 28, 8, p. 1736-8 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

    Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T. & Miguel, J. F. S., 08.2014, In: LEUKEMIA. 28, 8, p. 1573-85 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  15. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

    Panagiota, V., Thol, F., Markus, B., Fehse, B., Alchalby, H., Badbaran, A., Lehmann, U., Koenecke, C., Shahswar, R., Chaturvedi, A., Stadler, M., Eder, M., Göhring, G., Koenigsmann, M., Kloos, A., Trummer, A., Schroeder, T., Kobbe, G., Thiede, C., Platzbecker, U., Schlegelberger, B., Kreipe, H-H., Ganser, A., Kröger, N. & Heuser, M., 01.07.2014, In: LEUKEMIA. 28, 7, p. 1552-5 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Low frequency of calreticulin mutations in MDS patients

    Heuser, M., Panagiota, V., Koenecke, C., Fehse, B., Alchalby, H., Badbaran, A., Shahswar, R., Stadler, M., Eder, M., Göhring, G., Trummer, A., Schroeder, T., Kobbe, G., Thiede, C., Platzbecker, U., Schlegelberger, B., Kroeger, N., Ganser, A. & Thol, F., 21.05.2014, In: LEUKEMIA.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

    Atanackovic, D., Luetkens, T. & Kröger, N., 01.05.2014, In: LEUKEMIA. 28, 5, p. 993-1000 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion

    Ariës, I. M., Jerchel, I. S., van den Dungen, R. E. S. R., van den Berk, L. C. J., Boer, J. M., Horstmann, M. A., Escherich, G., Pieters, R. & den Boer, M. L., 20.02.2014, In: LEUKEMIA. 28, 9, p. 1828-1837

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. IMWG consensus on risk stratification in multiple myeloma

    Chng, W. J., Dispenzieri, A., Chim, C-S., Fonseca, R., Goldschmidt, H., Lentzsch, S., Munshi, N., Palumbo, A., Miguel, J. S., Sonneveld, P., Cavo, M., Usmani, S., Durie, B. G. M., Avet-Loiseau, H. & International Myeloma Working Group, 01.02.2014, In: LEUKEMIA. 28, 2, p. 269-77 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2013
  21. The MLL recombinome of acute leukemias in 2013

    Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., Cavé, H., Clappier, E., Mass-Malo, K., Zuna, J., Trka, J., De Braekeleer, E., De Braekeleer, M., Oh, S. H., Tsaur, G., Fechina, L., van der Velden, V. H. J., van Dongen, J. J. M., Delabesse, E., Binato, R., Silva, M. L. M., Kustanovich, A., Aleinikova, O., Harris, M. H., Lund-Aho, T., Juvonen, V., Heidenreich, O., Vormoor, J., Choi, W. W. L., Jarosova, M., Kolenova, A., Bueno, C., Menendez, P., Wehner, S., Eckert, C., Talmant, P., Tondeur, S., Lippert, E., Launay, E., Henry, C., Ballerini, P., Lapillone, H., Callanan, M. B., Cayuela, J. M., Herbaux, C., Cazzaniga, G., Kakadiya, P. M., Bohlander, S., Ahlmann, M., Choi, J. R., Gameiro, P., Lee, D. S., Krauter, J., Cornillet-Lefebvre, P., Te Kronnie, G., Schäfer, B. W., Kubetzko, S., Alonso, C. N., zur Stadt, U., Sutton, R., Venn, N. C., Izraeli, S., Trakhtenbrot, L., Madsen, H. O., Archer, P., Hancock, J., Cerveira, N., Teixeira, M. R., Lo Nigro, L., Möricke, A., Stanulla, M., Schrappe, M., Sedék, L., Szczepański, T., Zwaan, C. M., Coenen, E. A., van den Heuvel-Eibrink, M. M., Strehl, S., Dworzak, M., Panzer-Grümayer, R., Dingermann, T., Klingebiel, T. & Marschalek, R., 01.11.2013, In: LEUKEMIA. 27, 11, p. 2165-76 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. SETBP1 mutation analysis in 944 patients with MDS and AML

    Thol, F., Suchanek, K. J., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Kade, S., Löffeld, P., Banihosseini, S., Bug, G., Ottmann, O., Hofmann, W-K., Krauter, J., Kröger, N., Ganser, A. & Heuser, M., 01.10.2013, In: LEUKEMIA. 27, 10, p. 2072-5 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  23. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

    Schroeder, T., Fröbel, J., Cadeddu, R-P., Czibere, A., Dienst, A., Platzbecker, U., Bug, G., Uharek, L., Fenk, R., Germing, U., Kröger, N., Haas, R. & Kobbe, G., 01.09.2013, In: LEUKEMIA. 27, 9, p. 1910-3 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  24. MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients

    Nuber, N., Curioni-Fontecedro, A., Dannenmann, S. R., Matter, C., von Boehmer, L., Atanackovic, D., Knuth, A. & van den Broek, M., 01.08.2013, In: LEUKEMIA. 27, 8, p. 1767-9 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  25. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

    Schroeder, T., Czibere, A., Platzbecker, U., Bug, G., Uharek, L., Luft, T., Giagounidis, A., Zohren, F., Bruns, I., Wolschke, C., Rieger, K., Fenk, R., Germing, U., Haas, R., Kröger, N. & Kobbe, G., 01.06.2013, In: LEUKEMIA. 27, 6, p. 1229-35 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

    Albers, C., Leischner, H., Verbeek, M., Yu, C., Illert, A. L., Peschel, C., von Bubnoff, N. & Duyster, J., 06.2013, In: LEUKEMIA. 27, 6, p. 1416-8 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

    Fernández de Larrea, C., Kyle, R. A., Durie, B. G. M., Ludwig, H., Usmani, S., Vesole, D. H., Hajek, R., San Miguel, J. F., Sezer, O., Sonneveld, P., Kumar, S. K., Mahindra, A., Comenzo, R., Palumbo, A., Mazumber, A., Anderson, K. C., Richardson, P. G., Badros, A. Z., Caers, J., Cavo, M., LeLeu, X., Dimopoulos, M. A., Chim, C. S., Schots, R., Noeul, A., Fantl, D., Mellqvist, U-H., Landgren, O., Chanan-Khan, A., Moreau, P., Fonseca, R., Merlini, G., Lahuerta, J. J., Bladé, J., Orlowski, R. Z., Shah, J. J. & International Myeloma Working Group, 01.04.2013, In: LEUKEMIA. 27, 4, p. 780-91 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.

    Kröger, N., Zabelina, T., de Wreede, L., Berger, J., Alchalby, H., van Biezen, A., Milpied, N., Volin, L., Mohty, M., Leblond, V., Blaise, D., Finke, J., Schaap, N., Robin, M., de Witte, T. & European Group for Blood and Marrow Transplantation, 2013, In: LEUKEMIA. 27, 3, p. 604-609 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.

    van Gelder, M., de Wreede, L. C., Schetelig, J., van Biezen, A., Volin, L., Maertens, J., Robin, M., Petersen, E., de Witte, T., Kröger, N. & EBMT Chronic Malignancies Working Party, 2013, In: LEUKEMIA. 27, 4, p. 879-888 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. 2012
  31. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

    Sprüssel, A., Schulte, J. H., Weber, S., Necke, M., Händschke, K., Thor, T., Pajtler, K. W., Schramm, A., König, K., Diehl, L., Mestdagh, P., Vandesompele, J., Speleman, F., Jastrow, H., Heukamp, L. C., Schüle, R., Dührsen, U., Buettner, R., Eggert, A. & Göthert, J. R., 09.2012, In: LEUKEMIA. 26, 9, p. 2039-51 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia

    Hofmann, M., Große-Hovest, L., Nübling, T., Pyż, E., Bamberg, M. L., Aulwurm, S., Bühring, H-J., Schwartz, K., Haen, S. P., Schilbach, K., Rammensee, H-G., Salih, H. R. & Jung, G., 06.2012, In: LEUKEMIA. 26, 6, p. 1228-37 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.

    Ellinghaus, E., Stanulla, M., Richter, G., Ellinghaus, D., Te Kronnie, G., Cario, G., Cazzaniga, G., Horstmann, M., Panzer Grümayer, R., Cavé, H., Trka, J., Cinek, O., Teigler-Schlegel, A., ElSharawy, A., Häsler, R., Nebel, A., Meissner, B., Bartram, T., Lescai, F., Franceschi, C., Giordan, M., Nürnberg, P., Heinzow, B., Zimmermann, M., Schreiber, S., Schrappe, M. & Franke, A., 2012, In: LEUKEMIA. 26, 5, p. 902-909 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT.

    Pfeiffer, M. M., Schumm, M., Müller, I., Handgretinger, R. & Lang, P., 2012, In: LEUKEMIA. 26, 11, p. 2435-2439 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Management of treatment-emergent peripheral neuropathy in multiple myeloma.

    Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., Harousseau, J. L., Moreau, P., Avet-Loiseau, H., Lee, J. H., Cavo, M., Merlini, G., Voorhees, P., Chng, W. J., Mazumder, A., Usmani, S., Einsele, H., Comenzo, R., Orlowski, R., Vesole, D., Lahuerta, J. J., Niesvizky, R., Siegel, D., Mateos, M-V., Dimopoulos, M., Lonial, S., Jagannath, S., Bladé, J., Miguel, J. S., Morgan, G., Anderson, K. C., Durie, B. G. M. & Sonneveld, P., 2012, In: LEUKEMIA. 26, 4, p. 595-608 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

    Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., LeLeu, X., Hulin, C., Klein, S. K., Sonneveld, P., Siegel, D., Bladé, J., Goldschmidt, H., Jagannath, S., Miguel, J. S., Orlowski, R., Palumbo, A., Sezer, O., Rajkumar, S. V., Durie, B. G. M. & Group, I. M. W., 2012, In: LEUKEMIA. 26, 1, p. 149-157 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 2011
  38. In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease

    Hartmann, N., Leithäuser, F., Albers, C., Duyster, J., Möller, P., Debatin, K-M. & Strauss, G., 05.2011, In: LEUKEMIA. 25, 5, p. 848-55 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

    Otten, J., Schmitz, L., Vettorazzi, E., Schultze, A., Marx, A. H., Simon, R., Krauter, J., Loges, S., Sauter, G., Bokemeyer, C. & Fiedler, W., 01.02.2011, In: LEUKEMIA. 25, 2, p. 375-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.

    Schnittger, S., Bacher, U., Haferlach, C., Alpermann, T., Dicker, F., Sundermann, J., Kern, W. & Haferlach, T., 2011, In: LEUKEMIA. 25, 4, p. 615-621 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Kröger, N., Zabelina, T., Berger, J., Duske, H., Klyuchnikov, E., Binder, T., Stübig, T., Hildebrandt, Y., Atanackovic, D., Alchalby, H., Ayuketang Ayuk, F., Zander, A. R., Bacher, U. & Eiermann, T., 2011, In: LEUKEMIA. 25, 10, p. 1657-1661 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia.

    Escherich, G., Richards, S., Stork, L. C. & Vora, A. J., 2011, In: LEUKEMIA. 25, 6, p. 953-959 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.

    Bacher, U., Kern, W., Alpermann, T., Schnittger, S., Kohlmann, A., Klein, H-U., Dugas, M., Haferlach, C. & Haferlach, T., 2011, In: LEUKEMIA. 25, 8, p. 1361-1364 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.

    Schnittger, S., Bacher, U., Kern, W., Alpermann, T., Haferlach, C. & Haferlach, T., 2011, In: LEUKEMIA. 25, 8, p. 1297-1304 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

    Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., de Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kröger, N. & Rocha, V., 2011, In: LEUKEMIA. 25, 1, p. 75-81 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. 2010
  47. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.

    Escherich, G., Horstmann, M. A., Zimmermann, M., Janka-Schaub, G. E. & COALL study group, 01.02.2010, In: LEUKEMIA. 24, 2, p. 298-308 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

    Kyle, R. A., Durie, B. G. M., Rajkumar, S. V., Landgren, O., Blade, J., Merlini, G., Kröger, N., Einsele, H., Vesole, D. H., Dimopoulos, M., San Miguel, J., Avet-Loiseau, H., Hajek, R., Chen, W. M., Anderson, K. C., Ludwig, H., Sonneveld, P., Pavlovsky, S., Palumbo, A., Richardson, P. G., Barlogie, B., Greipp, P., Vescio, R., Turesson, I., Westin, J., Boccadoro, M. & Group, I. M. W., 2010, In: LEUKEMIA. 24, 6, p. 1121-1127 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.

    Zuurbier, L., Homminga, I., Calvert, V., Te Winkel, M. L., Buijs-Gladdines, J. G. C. A. M., Kooi, C., Smits, W. K., Sonneveld, E., Veerman, A. J. P., Kamps, W. A., Horstmann, M., Petricoin, E. F., Pieters, R. & Meijerink, J. P. P., 2010, In: LEUKEMIA. 24, 12, p. 2014-2022 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.

    Terpos, E., Dimopoulos, M. A., Sezer, O., Roodman, D., Abildgaard, N., Vescio, R., Tosi, P., Garcia-Sanz, R., Davies, F., Chanan-Khan, A., Palumbo, A., Sonneveld, P., Drake, M. T., Harousseau, J-L., Anderson, K. C., Durie, B. G. M. & Group, I. M. W., 2010, In: LEUKEMIA. 24, 10, p. 1700-1712 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. 2009
  52. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.

    Haferlach, T., Kohlmann, A., Klein, H-U., Ruckert, C., Dugas, M., Williams, P. M., Kern, W., Schnittger, S., Bacher, U., Löffler, H. & Haferlach, C., 2009, In: LEUKEMIA. 23, 5, p. 934-943 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.

    Kern, W., Haferlach, C., Bacher, U., Haferlach, T. & Schnittger, S., 2009, In: LEUKEMIA. 23, 7, p. 1361-1364 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).

    Niebuhr, B., Iwanski, G., Schwieger, M., Roscher, S., Stocking, C. & Cammenga, J., 2009, In: LEUKEMIA. 23, 5, p. 978-983 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. New insights to the MLL recombinome of acute leukemias.

    Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., Delabesse, E., de Oliveira, M. P., Cavé, H., Clappier, E., van Dongen, J. J. M., Balgobind, B. V., van den Heuvel-Eibrink, M. M., Beverloo, H. B., Panzer-Grümayer, R., Teigler-Schlegel, A., Harbott, J., Kjeldsen, E., Schnittger, S., Koehl, U., Gruhn, B., Heidenreich, O., Chan, L. C., Yip, S. F., Krzywinski, M., Eckert, C., Möricke, A., Schrappe, M., Alonso, C. N., Schäfer, B. W., Krauter, J., Lee, D. A., Zur Stadt, U., Te Kronnie, G., Sutton, R., Izraeli, S., Trakhtenbrot, L., Lo Nigro, L., Tsaur, G., Fechina, L., Szczepanski, T., Strehl, S., Ilencikova, D., Molkentin, M., Burmeister, T., Dingermann, T., Klingebiel, T. & Marschalek, R., 2009, In: LEUKEMIA. 23, 8, p. 1490-1499 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

    Knödler, A., Schmidt, S. M., Bringmann, A., Weck, M. M., Brauer, K. M., Holderried, T. A. W., Heine, A-K., Grünebach, F. & Brossart, P., 2009, In: LEUKEMIA. 23, 3, p. 535-544 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment.

    Haferlach, C., Bacher, U., Schnittger, S., Weiss, T., Kern, W. & Haferlach, T., 2009, In: LEUKEMIA.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review